Potential anticancer effect of free and nanoformulated Deferasirox for breast cancer treatment: in-vitro and in-vivo evaluation.
Nadeen Diaa Abdel-WahabMohamed Fawzi KabilIbrahim Mohamed El-SherbinyMohamed F SalamaGehad El-SayedEl-Said El-SherbiniPublished in: Drug development and industrial pharmacy (2024)
The newly developed DFX nanoform demonstrated a high potential as a promising therapeutic agent for BC treatment.